Assessment of chimerism in the setting of allogeneic hematopoietic cell transplantation

Molecular Pathology in Clinical Practice

Volumn , Issue , 2007, Pages 517-531

  Van Deerlin, Vivianna M ^a   Williams, Erica ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875458357     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-33227-7_46     Document Type: Chapter

References (26)

1. Bader P, Niethammer D, Willasch A, Kreyenberg H, Klingebiel T.How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant. 2005;35:107-119
2. Khan F, Agarwal A, Agrawal S. Significance of chimerism in hematopoietic stem cell transplantation: New variations on an old theme. Bone Marrow Transplant. 2004;34:1-12
3. McCann SR, Crampe M, Molloy K, Lawler M. Hemopoietic chimerism following stem cell transplantation. Transfus Apher Sci. 2005;32:55-61
4. Thiede C. Diagnostic chimerism analysis after allogeneic stem cell transplantation: New methods and markers. Am J Pharmacogenomics. 2004;4:177-187
5. Winiarski J, Mattsson J, Gustafsson A, et al. Engraftment and chimerism, particularly of T-And B-cells, in children undergoing allogeneic bone marrow transplantation. Pediatr Transplant. 1998;2: 150-156
6. Baron F, Storb R. Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: A review. Springer Semin Immunopathol. 2004;26:71-94
7. Slavin S. Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation. Int J Hematol. 2003;78:195-207
8. Slavin S.New strategies for bone marrow transplantation. Curr Opin Immunol. 2000;12:542-551
9. Massenkeil G, Nagy M, Lawang M, et al. Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved. Bone Marrow Transplant. 2003;31:339-345
10. Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2001;7:473-485
11. Gardiner N, Lawler M, O'Riordan JM, Duggan C, De Arce M, McCann SR. Monitoring of lineage-specific chimaerism allows early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukaemia. Bone Marrow Transplant. 1998;21:711-719
12. Valcarcel D, Martino R, Caballero D, et al. Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant. 2003; 31:387-392
13. Baron F, Little MT, Storb R. Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning. Blood Rev. 2005;19:153-164
14. Dewald G, Stallard R, Al Saadi A, et al. A multicenter investigation with interphase fluorescence in situ hybridization using X-And Y-chromosome probes. Am J Med Genet. 1998;76:318-326
15. Bennett P.Demystified microsatellites.Mol Pathol. 2000;53:177-183
16. Butler JM. Forensic DNA Typing: Biology and Technology Behind STR Markers. San Diego: Academic Press; 2001
17. Van Deerlin VM, Leonard DG. Bone marrow engraftment analysis after allogeneic bone marrow transplantation. Clin Lab Med. 2000;20:197-225
18. Fehse B, Chukhlovin A, Kuhlcke K, et al. Real-Time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation. J Hematother Stem Cell Res. 2001;10:419-425
19. Bader P, Beck J, Frey A, et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant. 1998;21:487-495
20. Oliver DH, Thompson RE, Griffin CA, Eshleman Jr. Use of single nucleotide polymorphisms (SNP) and real-Time polymerase chain reaction for bone marrow engraftment analysis. J Mol Diagn. 2000;2:202-208
21. Fredriksson M, Barbany G, Liljedahl U, Hermanson M, Kataja M, Syvanen AC. Assessing hematopoietic chimerism after allogeneic stem cell transplantation by multiplexed SNP genotyping using microarrays and quantitative analysis of SNP alleles. Leukemia. 2004;18:255-266
22. Alizadeh M, Bernard M, Danic B, et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-Time quantitative polymerase chain reaction. Blood. 2002;99: 4618-4625
23. Lion T. Summary: Reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection. Leukemia. 2003;17:252-254
24. Thiede C, Bornhauser M, Ehninger G. Evaluation of STR informativity for chimerism testing-comparative analysis of 27 STR systems in 203 matched related donor recipient pairs. Leukemia. 2004;18:248-254
25. Nollet F, Billiet J, Selleslag D, Criel A. Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing. Bone Marrow Transplant. 2001;28:511-518
26. Zhou M, Sheldon S, Akel N, Killeen AA. Chromosomal aneuploidy in leukemic blast crisis: A potential source of error in interpretation of bone marrow engraftment analysis by VNTR amplification. Mol Diagn. 1999;4:153-157